InvestorsHub Logo
Followers 140
Posts 11663
Boards Moderated 0
Alias Born 03/15/2011

Re: pphmtoolong post# 188367

Saturday, 08/30/2014 12:57:40 PM

Saturday, August 30, 2014 12:57:40 PM

Post# of 345783
For PPHM (IR) it (the sabotage dose switching) will not be over until:

- the Class Action appeal is berried (even though they know the outcome)

- the lawsuit against CSM is over

- the criminal case against the "she" will have been made or settled by disclosure of who's behind it.

Then they may come out of the bunker. Until then they'll see every question or action they don't understand as a possible interference or attempt of manipulation or possible incitement of an error on their behalve that may endanger their cases or PPHM as a hole. Normal, they don't know who the enemy is.

And you know what? I think that is, at least for the moment, the correct attitude.

That being said, disclosing some more detail about patient enrolment in 2nd ln NSCLC would hurt as it doesn't really fall in the above risk if it is done intelligently.

Peregrine Pharmaceuticals the Microsoft of Biotechnology! All In My Opinion. I am not advising anything, nor accusing anyone.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News